Ruth M Ruprecht

This inventor holds 7 USPTO granted patents and 5 published patent applications, plus 1 CIPO patent and 1 EPO patent. Top assignees: Dana-Farber-Cancer Institute Inc., Isis Innovation Limited, Texas Biomedical Research Institute. Active years: 1992-2021.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Ruth M Ruprecht. Retrieved from https://idiyas.com/inventor/ruth-m-ruprecht

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 7 (Patent Applications = 5)

% Patents Active = 85.7

CIPO Patents = 1 (Patent Applications = 1)

EPO Patents = 1 (Patent Applications = 2)

Average Co-Inventor Count = 1.6

ph-index = 1

Forward Citations = 6(Granted Patents)

Location History:

Brookline, MA (US) (1996)
Boston, MA (US) (1992 - 2018)
Lafayette, LA (US) (2021)
San Antonio, TX (US) (2023)

Company Filing History:

5 out of 1,268

Dana-Farber-Cancer Institute Inc.

patents

1 out of 330

Isis Innovation Limited

patents

1 out of 6

Texas Biomedical Research Institute

patents

4. 1 out of 834,570

Other

patents

where one patent can have more than one assignee

Years Active: 1992-2021

Loading Chart...

7 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11129889 - Recombinant HIV epitopes and uses thereof (2021-09-28),

2. 10125173 - HIV-1 V3 mimotopes capable of inducing cross-clade neutralizing antibodies (2018-11-13),

3. 9382546 - Process for making oligopeptides (2016-07-05),

4. 9334310 - HIV-1 V3 mimotopes capable of inducing cross-clade neutralizing antibodies (2016-05-10),

5. 8603490 - Modified human immunodeficiency virus clade C envelope polypeptides obtained from a zambian isolate (2013-12-10),

6. 5512281 - Mammalian model system and methods of testing immuno-or drug prophylaxis (1996-04-30),

7. 5132414 - Dideoxynucleoside-5'-phosphonoformic acid compounds (1992-07-21),

Profile summary based on public USPTO records.